Metformin's effect on exercise and postexercise substrate oxidation

International Journal of Sport Nutrition and Exercise Metabolism

Volumn 20, Issue 1, 2010, Pages 63-71

  Malin, Steven K ^a   Stephens, Brooke R ^a   Sharoff, Carrie G ^a   Hagobian, Todd A ^a   Chipkin, Stuart R ^a   Braun, Barry ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Biguanide; Exercise metabolism; Prediabetes; Type 2 diabetes

Indexed keywords

LIPID; METFORMIN; PLACEBO;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CALORIMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENERGY; EXERCISE; FEMALE; HUMAN; LIPID OXIDATION; MALE; NORMAL HUMAN; WORKLOAD;

EID: 76249125813     PISSN: 1526484X     EISSN: 15432742     Source Type: Journal    
DOI: 10.1123/ijsnem.20.1.63     Document Type: Article

References (36)

1. Achten, J., Gleeson, M., & Jeukendrup, A.E. (2002). Determination of the exercise intensity that elicits maximal fat oxidation. Medicine and Science in Sports and Exercise, 34(1), 92-97.
2. American Diabetes Association. (2007). Standards of medical care in diabetes-2007. Diabetes Care, 30(Suppl. 1), S4-S41.
3. Bielinski, R., Schutz, Y., & Jequier, E. (1985). Energy metabolism during the post-exercise recovery in man. The American Journal of Clinical Nutrition, 42(1), 69-82.
4. Bordenave, S., Flavier, S., Fedou, C., Brun, J.F., & Mercier, J. (2007). Exercise calorimetry in sedentary patients: Procedures based on short 3 min steps underestimate carbohydrate oxidation and overestimate lipid oxidation. Diabetes & Metabolism, 33(5), 379-384.
5. Braun, B., Eze, P., Stephens, B.R., Hagobian, T.A., Sharoff, C.G., Chipkin, S.R., et al. (2008). Impact of metformin on peak aerobic capacity. Applied Physiology, Nutrition, and Metabolism. Physiologie Appliquee, Nutrition et Metabolism, 33(1), 61-67.
6. Braun, B., & Horton, T. (2001). Endocrine regulation of exercise substrate utilization in women compared to men. Exercise and Sport Sciences Reviews, 29(4), 149-154.
7. Braun, B., Sharoff, C., Chipkin, S. R., & Beaudoin, F. (2004). Effects of insulin resistance on substrate utilization during exercise in overweight women. Journal of Applied Physiology (Bethesda, Md.: 1985), 97(3), 991-997.
8. Broeder, C.E., Brenner, M., Hofman, Z., Paijmans, I.J., Thomas, E.L., & Wilmore, J.H. (1991). The metabolic consequences of low and moderate intensity exercise with or without feeding in lean and borderline obese males. International Journal of Obesity, 15(2), 95-104.
9. Brooks, G. A., & Mercier, J. (1994). Balance of carbohydrate and lipid utilization during exercise: The "crossover" concept. Journal of Applied Physiology (Bethesda, Md.: 1985), 76(6), 2253-2261.
10. Dumortier, M., Brandou, F., Perez-Martin, A., Fedou, C., Mercier, J., & Brun, J.F. (2003). Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome. Diabetes & Metabolism, 29(5), 509-518.
11. Goodpaster, B.H., Katsiaras, A., & Kelley, D.E. (2003). Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes, 52(9), 2191-2197.
12. Gudat, U., Convent, G., & Heinemann, L. (1997). Metformin and exercise: No additive effect on blood lactate levels in health volunteers. Diabetic Medicine: A Journal of the British Diabetic Association, 14(2), 138-142.
13. Henderson, G.C., Fattor, J.A., Horning, M.A., Faghihnia, N., Johnson, M.L., Mau, T.L., et al. (2007). Lipolysis and fatty acid metabolism in men and women during the postexercise recovery period. The Journal of Physiology, 584(Pt 3), 963-981.
14. Horowitz, J.F. (2003). Fatty acid mobilization from adipose tissue during exercise. Trends in Endocrinology and Metabolism. TEM, 14(8), 386-392.
15. Horton, T. J., Pagliassotti, M. J., Hobbs, K., & Hill, J. O. (1998). Fuel metabolism in men and women during and after long-duration exercise. Journal of Applied Physiology (Bethesda, Md.: 1985), 85(5), 1823-1832.
16. Jeukendrup, A.E. (2002). Regulation of fat metabolism in skeletal muscle. Annals of the New York Academy of Sciences, 967, 217-235.
17. Kelley, D.E., He, J., Menshikova, E.V., & Ritov, V.B. (2002). Dysfunction of mitochondria in human skeletal muscle in Type 2 diabetes. Diabetes, 51(10), 2944-2950.
18. Kelley, D.E., & Mandarino, L.J. (2000). Fuel selection in human skeletal muscle in insulin resistance: A reexamination. Diabetes, 49(5), 677-683.
19. Kiens, B., & Richter, E.A. (1998). Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans. The American Journal of Physiology, 275(2 Pt 1), E332-E337.
20. Kimber, N.E., Heigenhauser, G.J., Spriet, L.L., & Dyck, D.J. (2003). Skeletal muscle fat and carbohydrate metabolism during recovery from glycogen-depleting exercise in humans. The Journal of Physiology, 548(Pt 3), 919-927.
21. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A., et al. (2002). Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine, 346(6), 393-403.
22. Kuo, C. C., Fattor, J. A., Henderson, G. C., & Brooks, G. A. (2005). Lipid oxidation in fit young adults during postexercise recovery. Journal of Applied Physiology (Bethesda, Md.: 1985), 99(1), 349-356.
23. Long, Y.C., & Zierath, J.R. (2006). AMP-activated protein kinase signaling in metabolic regulation. The Journal of Clinical Investigation, 116(7), 1776-1783.
24. Merrill, G.F., Kurth, E.J., Hardie, D.G., & Winder, W.W. (1997). AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. The American Journal of Physiology, 273(6 Pt. 1), E1107-E1112.
25. Nathan, D.M., Davidson, M.B., DeFronzo, R.A., Heine, R.J., Henry, R.R., Pratley, R., et al. (2007). Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care, 30(3), 753-759.
26. Orchard, T.J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., et al. (2005). The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The diabetes prevention program randomized trial. Annals of Internal Medicine, 142(8), 611-619.
27. Owen, M.R., Doran, E., & Halestrap, A.P. (2000). Evidence that metformin exerts its anti-diabetic effects through inhibition of Complex 1 of the mitochondrial respiratory chain. The Biochemical Journal, 348(Pt. 3), 607-614.
28. Perez-Martin, A., Dumortier, M., Raynaud, E., Brun, J.F., Fedou, C., Bringer, J., et al. (2001). Balance of substrate oxidation during submaximal exercise in lean and obese people. Diabetes & Metabolism, 27(4 Pt. 1), 466-474.
29. Peronnet, F., & Massicotte, D. (1991). Table of nonprotein respiratory quotient: An update. Canadian Journal of Sport Sciences. Journal Canadien Des Sciences Du Sport, 16(1), 23-29.
30. Phelain, J.F., Reinke, E., Harris, M.A., & Melby, C.L. (1997). Postexercise energy expenditure and substrate oxidation in young women resulting from exercise bouts of different intensity. Journal of the American College of Nutrition, 16(2), 140-146.
31. Randle, P.J. (1998). Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years. Diabetes/ Metabolism Reviews, 14(4), 263-283.
32. Romijn, J.A., Coyle, E.F., Hibbert, J., & Wolfe, R.R. (1992). Comparison of indirect calorimetry and a new breath 13C/12C ratio method during strenuous exercise. The American Journal of Physiology, 263(1 Pt. 1), E64-E71.
33. Romijn, J.A., Coyle, E.F., Sidossis, L.S., Gastaldelli, A., Horowitz, J.F., Endert, E., et al. (1993). Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. The American Journal of Physiology, 265(3 Pt. 1), E380-E391.
34. Simoneau, J.A., Veerkamp, J.H., Turcotte, L.P., & Kelley, D.E. (1999). Markers of capacity to utilize fatty acids in human skeletal muscle: Relation to insulin resistance and obesity and effects of weight loss. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 13(14), 2051-2060.
35. Winder, W.W. (2000). AMP-activated protein kinase: Possible target for treatment of Type 2 diabetes. Diabetes Technology & Therapeutics, 2(3), 441-448.
36. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., et al. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. The Journal of Clinical Investigation, 108(8), 1167-1174.